The ‘The Big Money Show’ panel has discussed the drug tariff strategy of President Donald Trump.
chairman Donald Trump On Thursday, letters were sent to 17 pharmaceutical companies about reducing the prices of medicine.
White House press secretary Karolin Lewit said in his press briefing that Trump sent letters after letters executive Order earlier this year.
“The President signed an executive order earlier this year to solve the problem of excessive drug pricing,” Levit said. “According to recent data, the prices that Americans are paying for brand name drugs are more than three times, similarly developed nations are paid. The President is firm to solve this problem and has taken further action. They have signed 17 letters to CEOs of pharmaceutical companies.”
President Donald Trump talks to the media as he meets the British Prime Minister Kir Stormer at the Trump Turnberry Golf Club in Scotland on 28 July 2025. (Getty Image / Getty Image)
Lewitt then read a letter sent to the CEO of Eli Lily, then said that all letters would be made available to the press after briefing.
Trump started posting copies of each letter on his social media platform, Truth social.
In his letter to Ellie Lily CEO David Ricks, Trump said that he signed an executive order on 12 May, titled “Most-Favorade-Nation Prescription Drug Pricing for American patients”. Order is intended “Stop global freeliding And guarantees that Americans pay equal prices blissful by other developed countries. ,
White House press secretary Karolin Lewitt speaks during a press briefing at the Brady Press Briefing Room at the White House on 31 July 2025. (Anna Moneymaker / Getty Image / Getty Images)
Price Control to reduce the cost of medicine to reduce Trump’s ‘wrong-bail’ effort: Specialist
Trump wrote, “Now, in the United States, the brands named brand are three times more than anywhere else for similar drugs.” “This unacceptable burden on hardworking American families ends with my administration. Most proposals received by the Trump administration to solve this important issue have promised the same shifting defects and requested policy changes, resulting in billions of dollars in the industry.”
Moving forward, Trump warned, only one thing he will accept to drug manufacturers “is a commitment” that provides immediate relief from the prices of drugs bloated to American families, and the end of free ride of American innovation By European and other developed nations. ,
He called Eli Lily & Co. and “Every manufacturer of business in our great country” to take action within 60 days. Trump stated that he should “pricate the most preferred nation for medicid, guarantee the most preferred nation pricing for newly launched drugs, has increased revenue abroad for American patients and taxpayers, and provides for direct purchase on most of the favorite nation pricing pricing.”
White House Press Secretary Karolin Lewit displayed a letter addressed to Eli Lily from President Donald Trump during a press briefing at the Brady Briefing Room of White House on 31 July 2025, DC. (Through Jim Watson / AFP Getty Image / Getty Image)
Trump said that his team, including the Secretary of Health and Human Services, Robert f. Kennedy Junior. And Administrator for Center for Medicare and Medicade Services Dr. Mehmat oz, are ready to apply conditions. The President said that he hoped that Ricks will engage in good faith immediately to give relief to American families with Kennedy and Oz “.
“Do not make any mistake, a collaborative effort to achieve global pricing equality would be the most effective way for companies, government and American patients,” Trump wrote. “But if you refuse to move, we will deploy every equipment in your arsenal to protect American families from continuous misuse of drug pricing practices. American is demanding low drug prices, and they need them today. Other nations have made freeloading on American innovation for a very long time, and it’s time to pay their proper share.”
Get Fox Business when you click here
Trump stated that he hoped on September 29 to eliminate the calls for each of his listed targets, the call for “important national priority” action.
Sixteen other companies received similar letters from Trump. They were: Abbavi, Bohringer Englandheim, Bristol Myers Squib, Novartis, Gilled Sciences, Inc., EMD Serono, Fizer, Novo Nordisk, Astrazenka, Majen, Gentec, Johnson & Johnson, GSK, Merc, Regoronon Pharmacy, and Sanki. Several letters have crossed the CEO’s last names and wrote in their place, their first name, suggesting a personal touch for the President’s demands for the big pharma chiefs.
